Michael A. Maldonado

1.9k total citations
51 papers, 1.4k citations indexed

About

Michael A. Maldonado is a scholar working on Rheumatology, Pathology and Forensic Medicine and Hematology. According to data from OpenAlex, Michael A. Maldonado has authored 51 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Rheumatology, 21 papers in Pathology and Forensic Medicine and 15 papers in Hematology. Recurrent topics in Michael A. Maldonado's work include Systemic Lupus Erythematosus Research (18 papers), Lymphoma Diagnosis and Treatment (18 papers) and Rheumatoid Arthritis Research and Therapies (17 papers). Michael A. Maldonado is often cited by papers focused on Systemic Lupus Erythematosus Research (18 papers), Lymphoma Diagnosis and Treatment (18 papers) and Rheumatoid Arthritis Research and Therapies (17 papers). Michael A. Maldonado collaborates with scholars based in United States, Sweden and Netherlands. Michael A. Maldonado's co-authors include Roy Fleischmann, Michael Schiff, Michael E. Weinblatt, Robert A. Eisenberg, R. Valente, Gustavo Citera, Désirée van der Heijde, Michael P. Madaio, Ayanbola Elegbe and Philip L. Cohen and has published in prestigious journals such as Blood, The Journal of Immunology and American Journal Of Pathology.

In The Last Decade

Michael A. Maldonado

48 papers receiving 1.3k citations

Peers

Countries citing papers authored by Michael A. Maldonado

Since Specialization

Citations

This map shows the geographic impact of Michael A. Maldonado's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael A. Maldonado with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael A. Maldonado more than expected).

Fields of papers citing papers by Michael A. Maldonado

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael A. Maldonado. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael A. Maldonado. The network helps show where Michael A. Maldonado may publish in the future.

Co-authorship network of co-authors of Michael A. Maldonado

This figure shows the co-authorship network connecting the top 25 collaborators of Michael A. Maldonado. A scholar is included among the top collaborators of Michael A. Maldonado based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael A. Maldonado. Michael A. Maldonado is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Efficacy and Safety of Subcutaneous Abatacept Plus Standard Treatment for Active Idiopathic Inflammatory Myopathy: Phase 3 Randomized Controlled Trial 2024 ·Arthritis & Rheumatology ·Rohit Aggarwal, Ingrid E. Lundberg, Yeong Wook Song, Aziz Shaibani, Victoria P. Werth, Michael A. Maldonado	5
2	Abatacept and non-melanoma skin cancer in patients with rheumatoid arthritis: a comprehensive evaluation of randomised controlled trials and observational studies 2023 ·Annals of the Rheumatic Diseases ·Teresa A. Simon, Lixian Dong, Samy Suissa, Kaleb Michaud, Sofia Pedro, Marc C. Hochberg, Maarten Boers, Johan Askling, Thomas Frisell, Anja Strangfeld, Yvette Meißner, Vadim Khaychuk, (unknown), Michael A. Maldonado	3
3	Differential Changes in ACPA Fine Specificity and Gene Expression in a Randomized Trial of Abatacept and Adalimumab in Rheumatoid Arthritis 2021 ·Rheumatology and Therapy ·Omar Jabado, Michael A. Maldonado, Michael Schiff, Michael E. Weinblatt, Roy Fleischmann, William H. Robinson, Aiqing He, Vishal Patel, Alex Greenfield, (unknown), David W. Galbraith, Seán Connolly	5
4	Urinary CD80 Discriminates Among Glomerular Disease Types and Reflects Disease Activity 2020 ·Kidney International Reports ·(unknown), John C. Lieske, George G. Klee, Sanjay Kumar, (unknown), (unknown), Shane A. Bobart, Diane E. Shevell, Michael A. Maldonado, Jonathan P. Troost, Marie C. Hogan	14
5	Efficacy of Abatacept and Adalimumab in Patients with Early Rheumatoid Arthritis With Multiple Poor Prognostic Factors: Post Hoc Analysis of a Randomized Controlled Clinical Trial (AMPLE) 2019 ·Rheumatology and Therapy ·Roy Fleischmann, Michael E. Weinblatt, (unknown), Michael A. Maldonado, E. Alemao, June Ye, Michael Schiff	11
6	Remodeling of the HDL proteome with treatment response to abatacept or adalimumab in the AMPLE trial of patients with rheumatoid arthritis 2018 ·Atherosclerosis ·Christina Charles‐Schoeman, (unknown), (unknown), Ani Shahbazian, (unknown), (unknown), Daniel E. Fürst, Veena K. Ranganath, Michael A. Maldonado, Terry Lee, Srinivasa T. Reddy	29
7	Randomized Clinical Trial Design to Assess Abatacept in Resistant Nephrotic Syndrome 2017 ·Kidney International Reports ·Howard Trachtman, Debbie S. Gipson, Michael J.G. Somers, Cathie Spino, Sharon G. Adler, Lawrence B. Holzman, Jeffrey B. Kopp, John R. Sedor, (unknown), Ayanbola Elegbe, Michael A. Maldonado, Anna Greka	17
8	De-Convolution of Whole Blood Transcriptomic Data From a Phase Jib, Randomized, Double-Blind, Placebo-Controlled Trial of Abatacept in Systemic Lupus Erythematosus 2016 ·Clinical and Experimental Rheumatology ·Soham Bandyopadhyay, Seán Connolly, Omar Jabado, S. Kelly, Michael A. Maldonado, René Westhovens, Peter Nash, JT Merrill, Robert Townsend	1
9	De-Convolution of Whole Blood Transcriptomic Data from a Phase IIb, Randomized, Double-Blind, Placebo-Controlled Trial of Abatacept in Systemic Lupus Erythematosus 2015 ·Queensland's institutional digital repository (The University of Queensland) ·(unknown), Seán Connolly, Omar Jabado, S. Kelly, Michael A. Maldonado, René Westhovens, Peter Nash, JT Merrill, Robert Townsend	1
10	Impact of baseline anti-cyclic citrullinated peptide-2 antibody concentration on efficacy outcomes following treatment with subcutaneous abatacept or adalimumab: 2-year results from the AMPLE trial 2015 ·Annals of the Rheumatic Diseases ·Jeremy Sokolove, Michael Schiff, Roy Fleischmann, Michael E. Weinblatt, Seán Connolly, Alyssa Johnsen, Jin Zhu, Michael A. Maldonado, Salil D. Patel, William H. Robinson	135
11	Head-to-head comparison of subcutaneous abatacept versus adalimumab for rheumatoid arthritis: two-year efficacy and safety findings from AMPLE trial 2013 ·Annals of the Rheumatic Diseases ·Michael Schiff, Michael E. Weinblatt, R. Valente, Désirée van der Heijde, Gustavo Citera, Ayanbola Elegbe, Michael A. Maldonado, Roy Fleischmann	208
12	Head‐to‐head comparison of subcutaneous abatacept versus adalimumab for rheumatoid arthritis: Findings of a phase IIIb, multinational, prospective, randomized study 2012 ·Arthritis & Rheumatism ·Michael E. Weinblatt, Michael Schiff, R. Valente, Désirée van der Heijde, Gustavo Citera, Cathy Zhao, Michael A. Maldonado, Roy Fleischmann	189
13	RANTES Deficiency Attenuates Autoantibody-Induced Glomerulonephritis 2010 ·Journal of Clinical Immunology ·Chun Xie, Kui Liu, (unknown), (unknown), (unknown), Tao Wang, (unknown), Michael A. Maldonado, Xin J. Zhou, Chandra Mohan	14
14	Decay-Accelerating Factor Ameliorates Systemic Autoimmune Disease in MRL/lpr Mice via Both Complement-Dependent and -Independent Mechanisms 2007 ·American Journal Of Pathology ·Takashi Miwa, Michael A. Maldonado, Lin Zhou, Koei Yamada, Gary S. Gilkeson, Robert A. Eisenberg, Wen‐Chao Song	25
15	The Role of Host CD4 T Cells in the Pathogenesis of the Chronic Graft-versus-Host Model of Systemic Lupus Erythematosus 2005 ·The Journal of Immunology ·Arpita Choudhury, Michael A. Maldonado, Philip L. Cohen, Robert A. Eisenberg	21
16	Chronic Graft-Versus-Host in Ig Knockin Transgenic Mice Abrogates B Cell Tolerance in Anti-Double-Stranded DNA B Cells 2002 ·The Journal of Immunology ·(unknown), (unknown), Michele L. Fields, Michael A. Maldonado, Michael P. Madaio, Jan Erikson, Martin Weigert, Robert A. Eisenberg	57
17	Deletion of Decay-Accelerating Factor (CD55) Exacerbates Autoimmune Disease Development in MRL/lpr Mice 2002 ·American Journal Of Pathology ·Takashi Miwa, Michael A. Maldonado, Lin Zhou, Xiujun Sun, Hong Luo, (unknown), Victoria P. Werth, Michael P. Madaio, Robert A. Eisenberg, Wen-Chao Song	80
18	CD86 (B7-2) Can Function to Drive MHC-Restricted Antigen-Specific CTL Responses In Vivo 1999 ·The Journal of Immunology ·Michael G. Agadjanyan, Jong J. Kim, Neil N. Trivedi, Darren M. Wilson, Behjatolah Monzavi‐Karbassi, Lake Morrison, Liesl Nottingham, Tzvete Dentchev, Anthony Tsai, Kesen Dang, Ara A. Chalian, Michael A. Maldonado, William V. Williams, David B. Weiner	57
19	The Role of Host (Endogenous) T Cells in Chronic Graft-Versus-Host Autoimmune Disease 1998 ·The Journal of Immunology ·(unknown), Michael A. Maldonado, Michael P. Madaio, Robert A. Eisenberg	41
20	Comparison of an enzyme‐linked immunosorbent assay for antibodies to β₂‐glycoprotein I and a conventional anticardiolipin immunoassay 1996 ·Arthritis & Rheumatism ·Robert Roubey, Michael A. Maldonado, (unknown)	67

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact